Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 14.50 ACUITE B | Downgraded | Issuer not co-operating* -
Bank Loan Ratings 5.00 - ACUITE A4 | Reaffirmed | Issuer not co-operating*
Total Outstanding 19.50 - -
Total Withdrawn 0.00 - -
* The issuer did not co-operate; based on best available information.
 
Rating Rationale

­Acuité has downgraded the long-term rating to 'ACUITE B’ (read as ACUITE B) from ‘ACUITE B+’ (read as ACUITE B plus) and reaffirmed the short term rating of ‘ACUITE A4’ (read as ACUITE A four) on the Rs.19.50 crore bank facilities of ­Ujin Pharmachem on account of information risk. The rating continues to be flagged as "Issuer Not-Cooperating" and is based on the best available information.


About the Company

­Ujin Pharmachem, established in 2005 is a Mumbai-based partnership firm promoted by Mr. Umang Mehta and Mr. Jinesh Sheth. The firm is engaged in trading of chemicals, bulk drugs and pharmaceutical products. The firm procures products from manufacturers in and around Mumbai and sells the finished product to traders and manufacturers all over India. The firm also imports around 45 percent of its total purchases from Turkey, USA, Holland and other European countries.­

 
Unsupported Rating
­Not Applicable
 
Non-cooperation by the issuer/borrower:

Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.

 
Limitation regarding information availability
Rating Sensitivity
­"No information provided by the issuer / available for Acuite to comment upon."
 
Liquidity Position
­"No information provided by the issuer / available for Acuite to comment upon."
 
Outlook
­Not Applicable
 
Other Factors affecting Rating
­None
 

Particulars Unit FY 18 (Actual) FY 17 (Actual)
Operating Income Rs. Cr. 199.47 137.48
PAT Rs. Cr. 1.75 1.20
PAT Margin (%) 0.88 0.87
Total Debt/Tangible Net Worth Times 1.95 2.14
PBDIT/Interest Times 1.55 1.43
Status of non-cooperation with previous CRA
­Not Applicable
 
Any other information
­None
 
Applicable Criteria
• Trading Entities: https://www.acuite.in/view-rating-criteria-61.htm
• Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
29 Nov 2023 Letter of Credit Short Term 5.00 ACUITE A4 (Reaffirmed & Issuer not co-operating*)
Cash Credit Long Term 14.50 ACUITE B+ (Reaffirmed & Issuer not co-operating*)
15 Sep 2022 Letter of Credit Short Term 5.00 ACUITE A4 (Reaffirmed & Issuer not co-operating*)
Cash Credit Long Term 14.50 ACUITE B+ (Reaffirmed & Issuer not co-operating*)
* The issuer did not co-operate; based on best available information.
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
Saraswat Bank Not avl. / Not appl. Cash Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 14.50 Simple ACUITE B | Downgraded | Issuer not co-operating* ( from ACUITE B+ )
Bank of Baroda Not avl. / Not appl. Letter of Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 5.00 Simple ACUITE A4 | Reaffirmed | Issuer not co-operating*
* The issuer did not co-operate; based on best available information.

Contacts

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in